AMA CPT® Assistant - 2020 Issue 1 (January)
Update to Reporting Meningococcal Vaccine (January 2020)
January 2020 page 11 Update to Reporting Meningococcal Vaccine For the Current Procedural Terminology (CPT®) 2020 code set, code 90619 was added to report a meningococcal conjugate vaccine using a tetanus-toxoid carrier. In addition, the descriptor of code 90734 was revised to allow differentiation of the precise type of meningococcal vaccine and carrier from code 90619. This article illustrates the intent of these codes with clinical examples and descriptions of the procedure for a typical patient. Vaccines, Toxoids 90734Meningococcal conjugate vaccine, serogroups A, C, W, Y, quadrivalent, diphtheria toxoid carrier (MenACWY-D) or CRM197 carrier (MenACWY-CRM), for intramuscular use...
Subscribe or sign in to view the full article.
Article Overview
This CPT Assistant article reviews a 2020 update related to meningococcal vaccine reporting. It covers how the vaccine product codes were aligned with specific vaccine products and carriers, how immunization administration reporting varies by patient age and counseling, and how the article’s clinical examples and procedural descriptions illustrate typical use cases. It is intended for coding professionals, clinicians, and billing staff working with immunization services and registry reporting.
Why This Topic Matters
Accurate vaccine reporting depends on matching the documented product and administration scenario to the correct CPT code family. This update is relevant to teams that code immunizations, support vaccine registry submissions, or manage documentation for preventive visits and vaccine administration.
Article Sections
-
Update to Reporting Meningococcal Vaccine
Introduces the CPT 2020 update and the general purpose of the article. Summarizes the coding topic and the context for the reporting changes.
-
Vaccines, Toxoids
Presents the vaccine product codes discussed in the article and the broad reporting context for meningococcal conjugate vaccines.
-
Immunization Administration for Vaccines/Toxoids
Reviews the administration code family referenced in the article and the general factors that affect reporting. Includes broad discussion of age, counseling, and administration scenarios.
-
Examples
Provides illustrative scenarios showing the general relationship between vaccine product reporting and immunization administration reporting.
-
Clinical Example (90619) / Description of Procedure (90619)
Presents an example case and accompanying procedure description associated with one of the vaccine product codes.
-
Clinical Example (90734) / Description of Procedure (90734)
Presents an example case and accompanying procedure description associated with the other vaccine product code.
What You Will Learn
- What the article covers in the 2020 meningococcal vaccine reporting update
- How the article distinguishes vaccine product reporting from administration reporting
- What broad factors influence selection among the immunization administration codes discussed
- How the article uses clinical examples to illustrate typical reporting situations
- Which organizations and reporting systems are mentioned in connection with vaccine documentation
Who Should Read This
- Medical coders
- Billing and reimbursement staff
- Physicians and qualified health care professionals
- Immunization registry personnel
- Practice administrators
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com
